Spero Therapeutics, Inc. (SPRO) Total assets 2016–2025
Spero Therapeutics, Inc. (SPRO) total assets at each fiscal year-end, per SEC filings.
$68.9MFY2025 · since FY2016: $13.8M → $68.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $68.9M | -37.7% |
| FY2024 | $110.5M | -39.4% |
| FY2023 | $182.4M | +46.1% |
| FY2022 | $124.8M | -27.0% |
| FY2021 | $171.1M | +11.5% |
| FY2020 | $153.5M | +44.6% |
| FY2019 | $106.1M | -17.8% |
| FY2018 | $129.0M | +38.0% |
| FY2017 | $93.5M | +578.8% |
| FY2016 | $13.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SPRO financial trends
SPRO RevenueSPRO Net incomeSPRO Net marginSPRO Gross profitSPRO Gross marginSPRO Operating incomeSPRO Operating marginSPRO Operating cash flowSPRO Free cash flowSPRO Capital expendituresSPRO Return on equitySPRO Stock buybacksSPRO Dividends paidSPRO Total liabilitiesSPRO Shareholders’ equitySPRO overview →